Proposed federal legislation in response to Pliva v Mensing would allow litigation against generic drug manufacturers - UPDATED

Democrats in the Senate and House introduced companion bills Wednesday that would permit generic drug companies to update warning information about the drugs they manufacture, a change that could allow patients to sue the companies for failing to warn about the risks of taking their drugs.  The New York Times has the details here.

UPDATE:  4/20/12:  the FDA law blog has more on this story here.